
Samarth Kulkarni, PhD
CEO & Chairman, CRISPR TherapeuticsDr Kulkarni is Chief Executive Officer and Chairman for CRISPR Therapeutics, and serves as Chairman of our Board of Directors.
He has significant expertise in strategy and operations in biotech and a wide range of related cutting-edge therapeutic technologies. He joined CRISPR in 2015 in the early stages of the company as Chief Business Officer and became CEO in 2017. Prior to joining CRISPR, he was a Partner at McKinsey, where he co-led the biotech practice and initiatives in areas such as personalized medicine and immunotherapy.
He currently serves on the Board of Directors of Centessa Pharmaceuticals, Black Diamond Therapeutics, and Repare Therapeutics. Additionally, he has previously served on the Board of Casebia Therapeutics and on the Board of Emerging Companies Section of the Biotechnology Innovation Organization (BIO).
Dr Kulkarni holds a BTech from the Indian Institute of Technology and PhD from the University of Washington.